The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Researchers used a blood protein wash to render brain tissue transparent down to 700 µm, witnessing live-firing activity ...

The study adds evidence that obesity treatment benefits depend on continued therapy, even when the delivery method changes.

The TECNO trial finds no clear reperfusion benefit from intra-arterial thrombolysis after thrombectomy in acute ischemic ...

In addition to reducing OR burden and its accompanying costs, offering nitrous oxide for in-office procedures can be easier ...

The rise of new weight-loss drugs could help reframe obesity as a societal failure driven by the food industry, rather than ...

Fecal metabolomic profiling in Crohn’s disease reveals distinct metabolite patterns linked to disease activity, location, and ...

UK government funding will enable whole-genome sequencing of 6000 patient samples, with researchers targeting immune and nervous system genes implicated in the disease.

Feeling more stressed is linked to irregular sleep patterns and problems in teens, whereas living in a supportive ...

The drug, widely used for chemotherapy-related nausea, may also be highly effective for symptoms caused by abdominal-pelvic ...

Empagliflozin and dapagliflozin show similar effectiveness in preventing cardiorenal outcomes among patients with type 2 ...

Adults with T1D who receive GLP-1-based therapy may have a lower risk for adverse cardiovascular outcomes and no significant ...